Class of Stock [Axis]
Common Stock, par value $0.0001 per share
Warrants, exercisable for one share of Common Stock
Related and Nonrelated Parties [Axis]
Related Party [Member]
Equity Components [Axis]
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Antidilutive Securities [Axis]
Share-Based Payment Arrangement, Option [Member]
Warrant [Member]
Plan Name [Axis]
2021 Omnibus Equity Incentive Plan [Member]
Nonqualified Inducement Stock Option Grant [Member]
Sale of Stock [Axis]
ATM Agreement [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Axis]
December 2025 PIPE [Member]
Class of Warrant or Right [Axis]
Pre-Funded Warrants [Member]
Series C Warrants [Member]
Series D Warrants [Member]
PIPE Warrants [Member]
Company Insiders [Member]
December 2025 PIPE Placement Agents Warrants [Member]
March 2025 Inducement Letter Agreement [Member]
New Series A Warrant [Member]
New Series B Warrant [Member]
March 2025 Financial Advisor Warrants [Member]
January 2025 PIPE [Member]
January 2025 PIPE Placement Agent Warrants [Member]
Class Of Stock [Axis]
March 2025 Warrant Inducement Series A Warrants [Member]
March 2025 Warrant Inducement Series B Warrants [Member]
January 2025 PIPE Warrants [Member]
January 2025 PIPE Repriced Warrants [Member]
Pre-IPO Series 1a Warrants [Member]
IPO Warrants [Member]
IPO Underwriter Warrants [Member]
March 2023 Offering Placement Agent Warrants [Member]
May 2023 PIPE Placement Agent Warrants [Member]
November 2023 Placement Agent Warrants [Member]
May 2024 Series A Common Warrants [Member]
May 2024 Placement Agent Warrants [Member]
September 2024 PIPE Placement Agent Warrants [Member]
December 2025 PIPE Series C Warrants [Member]
December 2025 PIPE Series D Warrants [Member]
December 2025 PIPE Placement Agent Warrants [Member]
Title and Position [Axis]
Employees [Member]
Director [Member]
New Employee [Member]
Financial Instrument [Axis]
Equity Option [Member]
Statement Of Income Location Balances [Axis]
Research and Development Expenses [Member]
Selling General and Administrative Expense [Member]
Award Date [Axis]
March Thirty First Twenty Seventeen [Member]
Intangible Asset, Indefinite-Lived, Class [Axis]
Licensing Agreements [Member]
First Amendment [Member]
Second Amendment [Member]
Product and Service [Axis]
Clinincal [Member]
Chemistry Manufacturing and Controls [Member]
Personnel Related [Member]
Compliance [Member]
Marketing Expense [Member]
Chief Financial Officer [Member]
Statement [Table]
Statement [Line Items]
Document Type
Amendment Flag
Amendment Description
Document Registration Statement
Document Annual Report
Document Quarterly Report
Document Transition Report
Document Shell Company Report
Document Shell Company Event Date
Document Period Start Date
Document Period End Date
Document Fiscal Period Focus
Document Fiscal Year Focus
Current Fiscal Year End Date
Entity File Number
Entity Registrant Name
Entity Central Index Key
Entity Primary SIC Number
Entity Tax Identification Number
Entity Incorporation, State or Country Code
Entity Address, Address Line One
Entity Address, Address Line Two
Entity Address, Address Line Three
Entity Address, City or Town
Entity Address, State or Province
Entity Address, Country
Entity Address, Postal Zip Code
Country Region
City Area Code
Local Phone Number
Extension
Written Communications
Soliciting Material
Pre-commencement Tender Offer
Pre-commencement Issuer Tender Offer
Title of 12(b) Security
No Trading Symbol Flag
Trading Symbol
Security Exchange Name
Title of 12(g) Security
Security Reporting Obligation
Annual Information Form
Audited Annual Financial Statements
Entity Well-known Seasoned Issuer
Entity Voluntary Filers
Entity Current Reporting Status
Entity Interactive Data Current
Entity Filer Category
Entity Small Business
Entity Emerging Growth Company
Elected Not To Use the Extended Transition Period
Document Accounting Standard
Other Reporting Standard Item Number
Entity Shell Company
Entity Public Float
Entity Bankruptcy Proceedings, Reporting Current
Entity Common Stock, Shares Outstanding
Documents Incorporated by Reference [Text Block]
Entity Listing, Par Value Per Share
Statement of Financial Position [Abstract]
Assets:
Cash and cash equivalents
Prepaid expenses and other current assets
Inventory
Total assets
Liabilities and Stockholders’ Equity:
Liabilities:
Accounts payable (including related party amounts of $0 and $86,250, respectively)
Accrued and other current liabilities (including related party amounts of $129,333 and $25,000, respectively)
Total liabilities
Commitments and Contingencies (see Note 6)
Stockholders’ Equity:
Common Stock, par value $0.0001, 250,000,000 shares authorized; 4,022,143 shares issued and outstanding as of March 31, 2026; 2,660,110 shares issued and outstanding as of December 31, 2025.
Additional paid-in capital
Accumulated deficit
Total stockholders’ equity
Total liabilities and stockholders’ equity
Accounts payable
Accrued and other current liabilities
Common stock, par value
Common stock, shares authorized
Common stock, shares issued
Common stock, shares outstanding
Income Statement [Abstract]
Operating expenses:
Research and development
Selling, general and administrative (including related party amounts of $190,583 and $0, respectively)
Total operating expenses
Loss from operations
Other income and expenses:
Interest income
Net loss
Net loss per share of Common Stock, basic
Net loss per share of Common Stock, diluted
Weighted-average basic Common Stock
Weighted-average diluted Common Stock
Defined Benefit Plan [Table]
Defined Benefit Plan Disclosure [Line Items]
Selling, general and administrative
Balance
Balance, shares
Issuance of Common Stock from ATM sales, net of issuance costs
Issuance of Common Stock from ATM sales, net of issuance costs, shares
Issuance of Common Stock upon exercise of pre-funded warrants
Issuance of Common Stock and warrants from January 2025 PIPE, net of issuance costs, shares
Stock-based compensation
Net loss
Issuance of Common Stock and warrants from January 2025 PIPE, net of issuance costs
Issuance of Common Stock upon exercise of pre-funded warrants, shares
Issuance of Common Stock and warrants from March 2025 Warrant Inducement, net of issuance costs
Issuance of Common Stock and warrants from March 2025 Warrant Inducement, net of issuance costs, shares
Balance
Balance, shares
Statement of Cash Flows [Abstract]
Cash flows from operating activities:
Adjustments to reconcile net loss to net cash used in operating activities:
Stock-based compensation
Increase (decrease) in cash resulting from changes in:
Prepaid expenses and other current assets
Inventory
Accounts payable
Accrued and other current liabilities
Net cash used in operating activities
Cash flows from financing activities:
Proceeds from issuance of Common Stock from ATM sales, net of issuance costs
Proceeds from issuance of Common Stock, pre-funded warrants, and warrants, net of issuance costs
Proceeds from exercise of pre-funded warrants
Payment of issuance costs
Net cash provided by financing activities
Net increase (decrease) in Cash and cash equivalents
Cash and cash equivalents at beginning of period
Cash and cash equivalents at end of period
Non-cash financing activities:
Issuance Common Stock upon exercise of pre-funded warrants
ATM issuance costs in accrued expenses
January 2025 PIPE issuance costs in accounts payable
March 2025 Warrant Inducement issuance costs in accounts payable
Pay vs Performance Disclosure [Table]
Executive Category [Axis]
Individual [Axis]
Adjustment to Compensation [Axis]
Measure [Axis]
Pay vs Performance Disclosure, Table
Company Selected Measure Name
Named Executive Officers, Footnote
Peer Group Issuers, Footnote
Changed Peer Group, Footnote
PEO Total Compensation Amount
PEO Actually Paid Compensation Amount
Adjustment To PEO Compensation, Footnote
Non-PEO NEO Average Total Compensation Amount
Non-PEO NEO Average Compensation Actually Paid Amount
Adjustment to Non-PEO NEO Compensation Footnote
Equity Valuation Assumption Difference, Footnote
Compensation Actually Paid vs. Total Shareholder Return
Compensation Actually Paid vs. Net Income
Compensation Actually Paid vs. Company Selected Measure
Total Shareholder Return Vs Peer Group
Compensation Actually Paid vs. Other Measure
Tabular List, Table
Total Shareholder Return Amount
Peer Group Total Shareholder Return Amount
Net Income (Loss)
Company Selected Measure Amount
Other Performance Measure, Amount
Adjustment to Compensation, Amount
PEO Name
Name
Non-GAAP Measure Description
Additional 402(v) Disclosure
Pension Benefits Adjustments, Footnote
Equity Awards Adjustments, Footnote
Erroneously Awarded Compensation Recovery [Table]
Restatement Determination Date [Axis]
Restatement Determination Date
Aggregate Erroneous Compensation Amount
Erroneous Compensation Analysis
Stock Price or TSR Estimation Method
Outstanding Aggregate Erroneous Compensation Amount
Aggregate Erroneous Compensation Not Yet Determined
Name
Forgone Recovery due to Expense of Enforcement, Amount
Forgone Recovery due to Violation of Home Country Law, Amount
Forgone Recovery due to Disqualification of Tax Benefits, Amount
Forgone Recovery, Explanation of Impracticability
Name
Compensation Amount
Restatement does not require Recovery
Awards Close in Time to MNPI Disclosures [Table]
Award Type [Axis]
Award Timing MNPI Disclosure
Award Timing Method
Award Timing Predetermined
Award Timing MNPI Considered
Award Timing, How MNPI Considered
MNPI Disclosure Timed for Compensation Value
Awards Close in Time to MNPI Disclosures, Table
Name
Underlying Securities
Exercise Price
Fair Value as of Grant Date
Underlying Security Market Price Change
Insider Trading Arrangements [Line Items]
Material Terms of Trading Arrangement
Name
Title
Rule 10b5-1 Arrangement Adopted
Non-Rule 10b5-1 Arrangement Adopted
Adoption Date
Rule 10b5-1 Arrangement Terminated
Non-Rule 10b5-1 Arrangement Terminated
Termination Date
Expiration Date
Arrangement Duration
Aggregate Available
Insider Trading Policies and Procedures [Line Items]
Insider Trading Policies and Procedures Adopted
Insider Trading Policies and Procedures Not Adopted
Accounting Policies [Abstract]
Organization and Basis of Presentation
Summary of Significant Accounting Policies
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Balance Sheet Details
Equity [Abstract]
Equity Securities
Equity Incentive Plan
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies
Segment Reporting [Abstract]
Segment Information
Related Party Transactions [Abstract]
Related Party Transactions
Subsequent Events [Abstract]
Subsequent Events
Use of Estimates
Segment Information
Cash and Cash Equivalents
Concentrations of Credit Risk
Fair Value Measurement
Inventory
Interest Income
Patent Costs
Research and Development Costs
Selling, General and Administrative Costs
Income Taxes
Stock-Based Compensation
Warrants
Comprehensive Loss
Net Loss Per Share of Common Stock
Recent Accounting Pronouncements
Schedule of Potentially Diluted Basic Earnings Per Share
Schedule of Balance Sheet Details
Schedule of Equity Securities
Schedule of Information of Outstanding Warrants
Schedule of Weighted Average Assumptions used for Stock Options
Schedule of Stock Based Compensation Expense
Schedule of Stock Option Activity
Schedule of Segment Financial Information
Reverse stock splits, description
Accumulated deficit
Cash used in operations
Antidilutive Security, Excluded EPS Calculation [Table]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total potentially dilutive securities
Cash, FDIC insured amount
Cash and cash equivalent deposits
Inventory:
Raw materials
Total inventory
Prepaid expenses and other current assets:
Prepaid insurance
Prepaid research and development costs
Prepaid marketing expenses
Prepaid annual subscriptions
Prepaid other
Deposit for inventory manufacturing
Deposit for property, plant and equipment
Total prepaid expenses and other current assets
Accrued and other current liabilities:
Accrued compensation and benefits
Accrued legal fees
Accrued consulting fees
Accrued other
Total accrued and other current liabilities
Accumulated Other Comprehensive Income (Loss) [Table]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Authorized, shares
Issued, shares
Reserved, shares
Outstanding, shares
Authorized, shares
Issued, shares
Reserved, shares
Outstanding, shares
Issued, shares
Outstanding, shares
Equity Incentive Plan, shares authorized
Issued, shares
Outstanding, shares
Nonqualified Inducement Stock Option Grant, shares authorized
Issued, shares
Authorized, shares
Issued, shares
Reserved, shares
Outstanding, shares
Class of Warrant or Right [Table]
Class of Warrant or Right [Line Items]
Quantity of Warrants Outstanding
Exercise Price
Expiration Date
Subsidiary or Equity Method Investee, Sale of Stock, Type [Table]
Subsidiary, Sale of Stock [Line Items]
ClassOfStockAxis [Axis]
Number of shares sold
Share Repurchase Program, Authorized, Amount
Share Repurchase Program, Remaining Authorized, Amount
Shares issued
Remained shares amount
Fixed commission rate on gross sales price of common stock, ATM
Sales commission
Warrants to purchase common stock
Common stock issuable upon exercise of warrants
Warrant gross proceeds
Aggregate purchase price
Net cash proceeds
Fair value
Expected term
Expected volatility
Risk free interest rate
Dividend yield
Gross proceeds from offering
Warrants to purchase common stock
Proceeds from exercise of warrants
Legal fees
Gross proceeds from common stock
Offering expenses
Warrants outstanding, shares
Preferred stock, shares authorized
Preferred stock, par value
Preferred stock, shares issued
Preferred stock, shares outstanding
Share price per share
Intrinsic value of warrants outstanding
Equity issuance costs
Reverse stock split description
Debt Securities, Held-to-Maturity, Allowance for Credit Loss [Table]
Debt Securities, Held-to-Maturity, Allowance for Credit Loss [Line Items]
Grant date fair value
Risk-free interest rate
Expected life in years
Stock, Class of Stock [Table]
Total
Number of options outstanding, balance
Weighted average exercise price, balance
Weighted average remaining contractual term in years
Number of options outstanding, options granted
Weighted average exercise price, options granted
Number of options outstanding, options exercised
Weighted average exercise price, options exercised
Number of options outstanding, options cancelled
Weighted average exercise price, options cancelled
Number of options outstanding, balance
Weighted average exercise price, balance
Number of options outstanding, options exerciseable
Weighted average exercise price, options exerciseable
Weighted average remaining contractual term exercisable (in years)
Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Number of shares authorized for issuance
Common stock reserved for issuance
Stock awards granted, exercisable period
Stock awards granted, vesting period
Granted shares
Exercise price
Share issued price per share
Intrinsic value of options outstanding and exercisable
Unrecognized stock based compensation expense
Weighted average exercise period
Total contract amount
Research and development
License aggregate amount
Subscription description
Segment Reporting [Table]
Segment Reporting [Line Items]
Total research and development
Total selling, general and administrative
Related Party Transaction [Table]
Related Party Transaction [Line Items]
Marketing expenses
Accounts payable and other accrued expenses
Fair value of options granted
Warrants, exercisable for one share of Common Stock.
Common Stock, par value $0.0001 per share.
Issuance of common stock upon exercise of warrants net of issuance costs amount.
Stock issued during period value issuance of common stock and warrants from march 2025 warrant inducement net of issuance costs.
Stock issued during period shares exercise of pre-funded warrants.
Stock issued during period shares issuance of common stock and warrants from march 2025 warrant inducement net of issuance costs.
Proceeds from issuance of common stock from ATM.
PIPE issuance costs in accounts payable.
Warrant Inducement issuance costs in accounts payable.
Issuance common stock upon exercise of prefunded warrants.
ATM issuance costs in accrued expenses.
Interest Income [Policy Text Block]
Prepaid research and development costs.
Prepaid marketing expenses.
Prepaid annual subscriptions.
Deposit for inventory manufacturing.
Deposit for property plant and equipment.
Accrued consulting fees.
2021 Omnibus Equity Incentive Plan [Member]
Shares authorized.
Shares reserved for future issuance.
Shares outstanding
Nonqualified inducement stock option grant shares authorized.
ATM Agreement [Member]
December Two Thousand Twenty Five PIPE [Member]
Pre-Funded Warrants [Member]
Series C Warrants [Member]
Series D Warrants [Member]
PIPE Warrants [Member]
Company Insiders [Member]
December 2025 PIPE Placement Agents Warrants [Member]
March 2025 Inducement Letter Agreement [Member]
New Series A Warrant [Member]
New Series B Warrant [Member]
March 2025 Financial Advisor Warrants [Member]
January 2025 PIPE [Member]
January Two Thousand Twenty Five PIPE Placement Agent Warrants [Member]
Class Of Stock [Axis]
Class of warrant or right outstanding intrinsic value.
Pre-IPO Series 1a Warrants [Member]
IPO Warrants [Member]
IPO Underwriter Warrants [Member]
March 2023 Offering Placement Agent Warrants [Member]
May 2023 PIPE Placement Agent Warrants [Member]
November 2023 Placement Agent Warrants [Member]
May 2024 Series A Common Warrants [Member]
May 2024 Placement Agent Warrants [Member]
September 2024 PIPE Placement Agent Warrants [Member]
January 2025 PIPE Warrants [Member]
January Two Thousand Twenty Five PIPE Repriced Warrants [Member]
March 2025 Warrant Inducement Series A Warrants [Member]
March 2025 Warrant Inducement Series B Warrants [Member]
December Two Thousand Twenty Five PIPE Series C Warrants [Member]
December Two Thousand Twenty Five PIPE Series D Warrants [Member]
December Two Thousand Twenty Five PIPE Placement Agent Warrants [Member]
Stock awards granted vesting period.
New Employee [Member]
License aggregate amount.
March Thirty First Twenty Seventeen [Member]
First Amendment [Member]
Second Amendment [Member]
Clinincal [Member]
Chemistry Manufacturing and Controls [Member]
Personnel Related [Member]
Compliance [Member]
Marketing Expense [Member]
Statement Of Income Location Balances [Axis]
Nonqualified Inducement Stock Option Grant [Member]
Research and Development Expenses [Member]
Selling General and Administrative Expense [Member]
Proceeds from issuance of common stock from ATM sales net of issuance costs.
Sale of stock other transactional fees.
Share based compensation arrangement by share based payment award options outstanding and exercisable intrinsic value.
Patent Costs [Policy Text Block]
Employees [Member]
Fixed commission rate on gross sales price of common stock pursuant to ATM.
Assets
Liabilities
Equity, Attributable to Parent
Liabilities and Equity
Operating Expenses
Operating Income (Loss)
Shares, Outstanding
Increase (Decrease) in Prepaid Expense and Other Assets
Increase (Decrease) in Inventories
Increase (Decrease) in Accounts Payable
Increase (Decrease) in Accrued Liabilities
Cash Provided by (Used in) Operating Activity, Including Discontinued Operation
Cash Provided by (Used in) Financing Activity, Including Discontinued Operation
Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation
Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation
Forgone Recovery, Individual Name
Outstanding Recovery, Individual Name
Awards Close in Time to MNPI Disclosures, Individual Name
Trading Arrangement, Individual Name
Segment Reporting, Policy [Policy Text Block]
Inventory, Policy [Policy Text Block]
Preferred Stock, Capital Shares Reserved for Future Issuance
Share-Based Compensation Arrangement by Share-Based Payment Award, Shares Issued in Period
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number
SharesAuthorized
SharesReservedForFutureIssuance
ShareOutstanding
Class of Warrant or Right, Exercise Price of Warrants or Rights
Warrants and Rights Outstanding, Maturity Date
Stock Issued During Period, Shares, Conversion of Units
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price
Other Expenses